The International Neuromodulation Society

The Fastest-Growing, Worldwide Multidisciplinary Body Devoted to Building Knowledge of Neuromodulation

The International Neuromodulation Society (INS) is a non-profit group of clinicians, scientists and engineers dedicated to the scientific development and awareness of neuromodulation – the alteration of nerve activity through targeted delivery of a stimulus, such as electrical stimulation or chemical agents, to specific neurological sites in the body. The San Francisco-based INS was formed in 1989 and educates and promotes the field through meetings, its peer-reviewed journal Neuromodulation: Technology at the Neural Interface, explanatory content, and chapter websites. The INS also provides information for patients and produces rolling news briefs about this rapidly evolving field.

The INS Peer-Reviewed Journal – 8 Issues a Year

The INS journal Neuromodulation: Technology at the Neural Interface has a growing Impact Factor and is indexed in Index Medicus, MEDLINE and Pubmed from its first issue in 1998. Members may log in to the members-only section to read the journal online.

journal cover

+Submit a Manuscript.+

What is Neuromodulation?

Medical Professionals can learn about various considerations concerning neuromodulation and clinic contacts. Once your preliminary questions have been answered, please use the Contact Us facility to find out more and to discuss specific objectives. Others may simply wish to join the INS and one of its related chapter societies, please use the Membership Application.

Clinical trials that involve a wide range of emerging neuromodulation approaches are listed on our Research page. Neuromodulation clinical trials address symptom control through nerve stimulation in such condition categories as:

If you are not a medical professional and you are searching for information about neuromodulation and how these types of treatment could benefit a specific condition such as treatment-resistant headache or other chronic pain syndromes, you may find the sections titled Therapies, About Neuromodulation or FAQs particularly helpful.

Members may log in and visit the members-only section’s Global Discussion Forum

Breaking News Share

Company Announces a 4-Year, $1 Million Preclinical Research Collaboration on Non-Invasive Vagus Nerve Stimulation and Neuroinflammation  

Aug. 9, 2018 - The company electroCore, Inc. announced it has entered a preclinical research partnership with Massachusetts General Hospital to study the mechanisms of inflammatory processes associated with central nervous system conditions, such as pain, trauma, and neurodegredation. The company will provide up to $1 million over four years for the studies, including two recently begun studies on non-invasive vagus nerve stimulation (VNS). One study focuses on persistent neuroinflammation and the neurological outcomes after concussive traumatic brain injury; the other, on effects on microglia cells and their association with the development and progression of Alzheimer’s disease. Previously, the company supported preclinical investigations at the same institution regarding neuroinflammatory mechanisms associated with migraine and their modulation by non-invasive VNS. (Globe Newswire)

Manitoba Clinic Seeks Participants for Study of Repetitive Transcranial Magnetic Stimulation in Depression

Aug. 8, 2018 - A Manitoba, Canada clinic will participate in a clinical trial of repetitive transcranial magnetic stimulation (rTMS) in treatment-resistant depression. The article states that although the provinces of Quebec and Saskatchewan cover rTMS for mood disorders, Manitoba Health decided against covering it in 2016. The clinic opened in 2012 and has a six-month waiting list. Its management has been fundraising and applying for grants to help cover costs for patients who cannot afford to pay for the treatment. (CBC)

Paper Presents Data on the Use of Deep Brain Stimulation in Meige Syndrome

Aug. 7, 2018 - In a two-patient case study of deep brain stimulation of the globus pallidus interna to address disabling muscle contractions of Meige syndrome, the authors in the U.K. and Portugal included a literature review of 82 cases, with pooled data showing a 60% improvement at a mean follow-up of about five years. The two patients in the case study were followed for two years, and improved motor symptoms of their craniocervical dystonia. (Neurology Advisor)

Large Dataset Analysis: From 57 - 72% Success for Sacral Nerve Stimulation Trials

Aug. 5, 2018 - An analysis of 1,396 patients who were trialed for a sacral nerve stimulation system from 2005 - 2011 in California found trial success rates of 72% for overactive bladder, 69% for urgency/frequency, 68% for interstitial cystitis, 67% for neurogenic bladder, and 57% for urinary retention. The analysis used non-public data from the California Office of Statewide Planning and Development's ambulatory surgery database. The article noted that although the rates were less than at some academic centers, they were better than previously reported tor Medicare beneficiaries. (Uro Today)

Percutaneous Neurostimulation Model for Overactive Bladder Investigates Activation of Saphenous Nerve  

Aug. 4, 2018 - Researchers explored the extent to which percutaneous tibial nerve stimulation co-activates the adjacent saphenous nerve, which animal studies indicate can evoke a bladder-inhibitory reflex. In their finite element model, they determined the electrode location and stimulation amplitude were important variables. (Uro Today)

Panel Evaluates Appropriateness of Treatment Options for Persistent Pain After Surgery

July 25, 2018 - Eight members of the International Neuromodulation Society are among the 19 neurosurgeons, pain specialists, and orthopedic surgeons who assessed appropriateness of four treatment options for 210 clinical scenarios of persistent pain after back surgery. The four treatment options were conservative, minimally invasive, neurostimulation, and re-operation. Neurostimulation was considered appropriate for predominant neuropathic leg pain in the absence of conditions that may require surgical intervention. (European Spine Journal)

To see select neuromodulation news by category, as well as news about the INS in particular, please visit the Newsroom. To see archived news briefs dating back to January 2011, visit the News Archive.

Continue Reading News Briefs
Last Updated on Monday, December 12, 2016 10:01 AM